» Articles » PMID: 22723427

EphB2 Activity Plays a Pivotal Role in Pediatric Medulloblastoma Cell Adhesion and Invasion

Abstract

Eph/ephrin signaling has been implicated in various types of key cancer-enhancing processes, like migration, proliferation, and angiogenesis. In medulloblastoma, invading tumor cells characteristically lead to early recurrence and a decreased prognosis. Based on kinase-activity profiling data published recently, we hypothesized a key role for the Eph/ephrin signaling system in medulloblastoma invasion. In primary medulloblastoma samples, a significantly higher expression of EphB2 and the ligand ephrin-B1 was observed compared with normal cerebellum. Furthermore, medulloblastoma cell lines showed high expression of EphA2, EphB2, and EphB4. Stimulation of medulloblastoma cells with ephrin-B1 resulted in a marked decrease in in vitro cell adhesion and an increase in the invasion capacity of cells expressing high levels of EphB2. The cell lines that showed an ephrin-B1-induced phenotype possessed increased levels of phosphorylated EphB2 and, to a lesser extent, EphB4 after stimulation. Knockdown of EphB2 expression by short hairpin RNA completely abolished ephrin ligand-induced effects on adhesion and migration. Analysis of signal transduction identified p38, Erk, and mTOR as downstream signaling mediators potentially inducing the ephrin-B1 phenotype. In conclusion, the observed deregulation of Eph/ephrin expression in medulloblastoma enhances the invasive phenotype, suggesting a potential role in local tumor cell invasion and the formation of metastases.

Citing Articles

Development of an orthotopic medulloblastoma zebrafish model for rapid drug testing.

van Bree N, Oppelt A, Lindstrom S, Zhou L, Boutin L, Coyle B Neuro Oncol. 2024; 27(3):779-794.

PMID: 39383211 PMC: 11889719. DOI: 10.1093/neuonc/noae210.


Comprehensive pan-cancer analysis reveals EPHB2 is a novel predictive biomarker for prognosis and immunotherapy response.

Xu S, Zheng Y, Ye M, Shen T, Zhang D, Li Z BMC Cancer. 2024; 24(1):1064.

PMID: 39198775 PMC: 11351591. DOI: 10.1186/s12885-024-12843-0.


The Clinical Relevance of the EPH/Ephrin Signaling Pathway in Pediatric Solid and Hematologic Malignancies.

Chatzikalil E, Stergiou I, Papadakos S, Konstantinidis I, Theocharis S Int J Mol Sci. 2024; 25(7).

PMID: 38612645 PMC: 11011407. DOI: 10.3390/ijms25073834.


EphrinA5 regulates cell motility by modulating Snhg15/DNA triplex-dependent targeting of DNMT1 to the Ncam1 promoter.

Bora Yildiz C, Kundu T, Gehrmann J, Koesling J, Ravaei A, Wolff P Epigenetics Chromatin. 2023; 16(1):42.

PMID: 37880732 PMC: 10601256. DOI: 10.1186/s13072-023-00516-4.


A preliminary study on the mechanism of VASH2 in childhood medulloblastoma.

Liu W, Fu Y, Wang M, Zhao J, Chen J, Wang Y Sci Rep. 2023; 13(1):17153.

PMID: 37821528 PMC: 10567924. DOI: 10.1038/s41598-023-42869-6.


References
1.
Zou J, Wang B, Kalo M, Zisch A, Pasquale E, Ruoslahti E . An Eph receptor regulates integrin activity through R-Ras. Proc Natl Acad Sci U S A. 1999; 96(24):13813-8. PMC: 24147. DOI: 10.1073/pnas.96.24.13813. View

2.
Sikkema A, Diks S, den Dunnen W, Ter Elst A, Scherpen F, Hoving E . Kinome profiling in pediatric brain tumors as a new approach for target discovery. Cancer Res. 2009; 69(14):5987-95. DOI: 10.1158/0008-5472.CAN-08-3660. View

3.
Louis D, Ohgaki H, Wiestler O, Cavenee W, Burger P, Jouvet A . The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 2007; 114(2):97-109. PMC: 1929165. DOI: 10.1007/s00401-007-0243-4. View

4.
Truitt L, Freywald T, DeCoteau J, Sharfe N, Freywald A . The EphB6 receptor cooperates with c-Cbl to regulate the behavior of breast cancer cells. Cancer Res. 2010; 70(3):1141-53. DOI: 10.1158/0008-5472.CAN-09-1710. View

5.
Bobola M, Silber J, Ellenbogen R, Geyer J, Blank A, Goff R . O6-methylguanine-DNA methyltransferase, O6-benzylguanine, and resistance to clinical alkylators in pediatric primary brain tumor cell lines. Clin Cancer Res. 2005; 11(7):2747-55. DOI: 10.1158/1078-0432.CCR-04-2045. View